Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback